Pictet Asset Management (Switzerland)’s ImmunityBio IBRX Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio IBRX Stock Details IBRX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$59.9K	Sell
2023 Q1	$4.41M	Buy
2022 Q4	$4.29M	Buy
2022 Q3	$3.17M	Buy
2022 Q2	$1.64M	Buy
2022 Q1	$2.31M	Hold
2021 Q4	$2.51M	Buy
2021 Q3	$3.03M	Buy